{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:50:09Z","timestamp":1770263409154,"version":"3.49.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a rare autoimmune disease of the central nervous system that affects the meninges, brain, spinal cord, and optic nerves. GFAP astrocytopathy can coexist with a variety of antibodies, which is known as overlap syndrome. Anti-NMDAR-positive encephalitis overlap syndrome has been reported; however, encephalitis overlap syndrome with both anti-NMDAR and sulfatide-IgG positivity has not been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>The patient was a 50-year-old male who was drowsy and had chills and weak limbs for 6 months. His symptoms worsened after admission to our hospital with persistent high fever, dysphoria, gibberish, and disturbance of consciousness. Positive cerebrospinal fluid NMDA, GFAP antibodies, and serum sulfatide antibody IgG were positive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Autoimmune GFAP astrocytopathy with anti-NMDAR and sulfatide-IgG-positive encephalitis overlap syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>In addition to ventilator support and symptomatic supportive treatment, step-down therapy with methylprednisolone (1000\u2009mg\/d, halved every 3 days) and pulse therapy with human immunoglobulin (0.4\u2009g\/(kg d) for 5 days) were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>After 6 days of treatment, the patient condition did not improve, and the family signed up to give up the treatment and left the hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Patients with autoimmune GFAP astrocytopathy may be positive for anti-NMDAR and sulfatide-IgG, and immunotherapy may be effective in patients with severe conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Autoimmune GFAP astrocytopathy with nonspecific symptoms is rarely reported and is easy to be missed and misdiagnosed. GFAP astrocytopathy should be considered in patients with fever, headache, disturbance of consciousness, convulsions, and central infections that do not respond to antibacterial and viral agents. Autoimmune encephalopathy-related antibody testing should be performed as soon as possible, early diagnosis should be confirmed, and immunomodulatory therapy should be administered promptly.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000038983","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:09:34Z","timestamp":1720796974000},"page":"e38983","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Autoimmune glial fibrillary acidic protein astrocytopathy with anti-NMDAR and sulfatide-IgG-positive encephalitis overlap syndrome: A case report and literature review"],"prefix":"10.1097","volume":"103","author":[{"given":"Ruo-mei","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Rheumatology, The First Hospital Affiliated to Kunming Medical University, Kunming, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-rong","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Emergency, The First Hospital Affiliated to Kunming Medical University, Kunming, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-hong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, The six Hospital Affiliated to Kunming Medical University, Yuxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Emergency, The Third People\u2019s Hospital of Yunnan Province, Kunming, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-chun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Emergency, The First Hospital Affiliated to Kunming Medical University, Kunming, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Emergency, The First Hospital Affiliated to Kunming Medical University, Kunming, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3728-2350","authenticated-orcid":false,"given":"Ming-wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Emergency, Dali Bai Autonomous Prefecture People\u2019s Hospital, Dali, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260204","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature.","volume":"9","author":"Shan","year":"2018","journal-title":"Front Immunol"},{"key":"R2-20260204","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ene.13531","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study.","volume":"25","author":"Long","year":"2018","journal-title":"Eur J Neurol"},{"key":"R3-20260204","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jnnp-2017-316583","article-title":"Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.","volume":"89","author":"Iorio","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-20260204","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s00415-020-09869-2","article-title":"Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy.","volume":"267","author":"Ding","year":"2020","journal-title":"J Neurol"},{"key":"R5-20260204","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fneur.2018.00251","article-title":"Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies.","volume":"9","author":"Yang","year":"2018","journal-title":"Front Neurol"},{"key":"R6-20260204","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis.","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"key":"R7-20260204","doi-asserted-by":"crossref","first-page":"e200146","DOI":"10.1212\/NXI.0000000000200146","article-title":"Visual system involvement in glial fibrillary acidic protein astrocytopathy: two case reports and a systematic literature review.","volume":"10","author":"Greco","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R8-20260204","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1007\/s00415-023-11908-7","article-title":"Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease.","volume":"270","author":"Theuriet","year":"2023","journal-title":"J Neurol"},{"key":"R9-20260204","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients.","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol"},{"key":"R10-20260204","doi-asserted-by":"crossref","first-page":"1106490","DOI":"10.3389\/fimmu.2023.1106490","article-title":"Clinical, imaging features and outcomes of patients with anti-GFAP antibodies: a retrospective study.","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"R11-20260204","doi-asserted-by":"crossref","first-page":"1136955","DOI":"10.3389\/fimmu.2023.1136955","article-title":"Clinical characteristics and prognostic factors for short-term outcomes of autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective analysis of 33 patients.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"R12-20260204","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/atm-19-330","article-title":"Detection and significance of glial fibrillary acidic protein antibody in autoimmuneastocytopathy and related diseases.","volume":"11","author":"Huang","year":"2023","journal-title":"Ann Transl Med"},{"key":"R13-20260204","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-510X(00)00342-7","article-title":"Anti-sulfatide IgM antibodies in peripheral neuropathy.","volume":"176","author":"Carpo","year":"2000","journal-title":"J Neurol Sci"},{"key":"R14-20260204","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/acn3.51954","article-title":"Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.","volume":"11","author":"Farah","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"R15-20260204","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s13760-023-02268-0","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: clinical analysis and review of 15 cases.","volume":"123","author":"Lan","year":"2023","journal-title":"Acta Neurol Belg"},{"key":"R16-20260204","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease.","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol"},{"key":"R17-20260204","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1212\/NXI.0000000000000663","article-title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient.","volume":"7","author":"Cellucci","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R18-20260204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2019.04.004","article-title":"Clinical characteristics of autoimmune GFAP astrocytopathy.","volume":"332","author":"Kimura","year":"2019","journal-title":"J Neuroimmunol"},{"key":"R19-20260204","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s13760-020-01361-y","article-title":"Glial fibrillary acidic protein (GFAP)-antibody in children with focal seizures of undetermined cause.","volume":"121","author":"Sava\u015f","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"R20-20260204","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000479948","article-title":"Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 Cases.","volume":"24","author":"Yang","year":"2017","journal-title":"Neuroimmunomodulation"},{"key":"R21-20260204","first-page":"67","article-title":"Clinical features of autoimmune glial fibrillary acidic protein astrocytopathy in children: an analysis of 34 cases.","volume":"25","author":"Wang","year":"2023","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"R22-20260204","doi-asserted-by":"crossref","first-page":"761354","DOI":"10.3389\/fimmu.2021.761354","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in children: a retrospective analysis of 35 Cases.","volume":"12","author":"Fang","year":"2021","journal-title":"Front Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:01:14Z","timestamp":1770213674000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":22,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038983","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}